Friday, April 17, 2026

Establishment Labs The First Costa Rica Company To Go Public On A U.S. Exchange

Thursday was a big day for Juan José Chacón-Quirós, also known as “JJ.” His company, Establishment Labs, became the first company headquartered in Costa Rica, to go public on an American stock exchange.

Establishment Labs, the first Costa Rican company to go public on a U.S. exchangeEstablishment Labs

“Today’s listing on Nasdaq represents a significant milestone for Establishment Labs and our shareholders,” said the company statement. “It’s an honor to be the first company headquartered in Costa Rica to be listed on a major stock exchange in the United States.”

“We welcome Establishment Labs to the Nasdaq family, and look forward to supporting their continued success,” said Joe Brantuk, Vice President of Nasdaq. “Establishment Labs continuously works to improve patient safety and aesthetic outcomes while simultaneously working towards its entry into the U.S. market.”

Founded in 2004, Establishment Labs (NASDAQ:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. And the first breast aesthetics IPO in 3 years.

Chacón-Quirós didn’t happen upon medical innovation by accident. He is the son and brother of a plastic surgeon, his mother is an obstetric nurse and his wife is a doctor, who have been a tremendous influence on him. He says that “my father taught me everything that existed, and my mother taught me everything that was missing.”

 

 

- A word from our sponsors -

spot_img

Latest Stories

- A word from our sponsors -

th>

¢461.96 BUY

¢466.89 SELL

/
27 March 2026 - At The Banks - Source: BCCR

Most Popular

More stories ...

- A word from our sponsors -

spot_img

Discover more from Q COSTA RICA

Subscribe now to keep reading and get access to the full archive.

Continue reading